
|
Section |
Page |
|
Letter
to Shareholders and Management’s Discussion of Fund
Performance |
|
|
Summary
of Certain Unaudited Portfolio Characteristics |
|
|
Fees
and Expenses |
|
|
Statement
of Assets and Liabilities |
|
|
Schedule
of Investments |
|
|
Statement
of Operations |
|
|
Statements
of Changes in Net Assets |
|
|
Statement
of Cash Flows |
|
|
Financial
Highlights |
|
|
Notes
to Financial Statements |
|
|
Dividend
Reinvestment Plan |
|
|
Portfolio
Proxy Voting Policies and Proxy Voting Record |
|
|
Additional
Information |



|
Summary
of Underlying Portfolio | |
|
Number
of Unique Underlying Loan Obligors |
1,423 |
|
Number
of Underlying Loans |
1,850 |
|
Aggregate
Balance of Underlying Loans |
$17.89
Billion |
|
Average
Individual Loan Obligor Exposure |
0.07% |
|
Currency:
USD Exposure |
100.00% |
|
Aggregate
Indirect Exposure to Senior Secured Loans |
97.18% |
|
Weighted
Average Junior OC Cushion |
4.18% |
|
Weighted
Average Market Price of Loan Collateral |
94.32 |
|
Weighted
Average Remaining CLO Reinvestment Period |
3.28
years |
|
CCIF’s
Last 12 Month Default Rate including Distressed Exchanges of
Underlying
Loans |
1.18% |
|
Loan
Market Default Rate including Distressed
Exchanges |
3.04% |
Top
10 Underlying Obligors | |
|
Obligor |
%
Total |
|
TransDigm |
0.60% |
|
Hologic |
0.46% |
|
TIBCO
Software |
0.44% |
|
Citadel
Securities LP |
0.44% |
|
Jane
Street Group |
0.44% |
|
Acrisure |
0.42% |
|
Quikrete
Companies |
0.41% |
|
Sedgwick
Claims Management Service |
0.40% |
|
Ensemble
RCM |
0.40% |
|
Belron
FIN 2019 |
0.40% |
|
Total |
4.41% |
Top
10 Industries of Underlying Obligors | |
|
Industry |
%
Total |
|
Healthcare
& Pharmaceuticals |
12.13% |
|
High
Tech |
12.07% |
|
Banking,
Finance, Insurance & Real Estate |
10.25% |
|
Services:
Business |
8.62% |
|
Hotels,
Gaming & Leisure |
5.15% |
|
Capital
Equipment |
4.81% |
|
Beverage,
Food & Tobacco |
4.37% |
|
Construction
& Building |
4.08% |
|
Aerospace
& Defense |
3.81% |
|
Energy:
Oil & Gas |
3.66% |
|
Total |
68.95% |




|
SHAREHOLDER
TRANSACTION FEES |
||
|
Sales
load |
|
(1) |
|
Offering
expenses borne by the Fund |
|
(2) |
|
Dividend
reinvestment plan expenses |
|
(3) |
|
Total
shareholder transaction fees |
—% |
(4) |
|
ESTIMATED
ANNUAL FUND EXPENSES
(as
a percentage of net assets attributable to common
shares) |
||
|
Management
Fee |
|
(5) |
|
Incentive
Fee payable under Investment Advisory Agreement
(17.5%) |
|
(6) |
|
Interest
payments and fees on borrowed funds |
|
(7) |
|
Other
Expenses |
|
(8) |
|
Total
annual fund expenses |
|
|
Example |
1
Year |
3
Years |
5
Years |
10
Years |
|
Expenses
on a $1,000 investment, assuming a 5%
annual
return |
$ |
$ |
$ |
$ |
|
March
31, 2026 | ||
|
ASSETS |
||
|
Investments,
at fair value (cost $174,665,811) |
$122,889,556 | |
|
Cash
and cash equivalents |
2,812,913 | |
|
Interest
receivable |
3,610,272 | |
|
Deferred
financing costs |
560,107 | |
|
Prepaid
expenses |
163,490 | |
|
Total
assets |
$130,036,338 | |
|
LIABILITIES |
||
|
Preferred
Shares (net of unamortized deferred issuance costs of $1,744,233) (Note
7) |
$49,272,767 | |
|
Secured
credit facility |
8,000,000 | |
|
Incentive
fee payable |
253,737 | |
|
Management
fee payable |
393,621 | |
|
Professional
fees payable |
309,736 | |
|
Interest
payable |
261,081 | |
|
Administration
and custodian fees payable |
256,427 | |
|
Other
payables and accrued expenses |
439,495 | |
|
Total
liabilities |
$59,186,864 | |
|
COMMITMENTS
AND CONTINGENCIES (Note 8) |
||
|
Net
Assets |
$70,849,474 | |
|
COMPOSITION
OF NET ASSETS |
||
|
Paid-in
capital |
$151,629,695 | |
|
Total
distributable earnings (losses) |
(80,780,221) | |
|
Total
Net Assets |
$70,849,474 | |
|
Common
shares outstanding (no par value) |
21,198,622 | |
|
Net
asset value per share of common stock |
$3.34 |
|
Issuer
(1)(7) |
Investment
Description |
Acquisition
Date
(2) |
Principal
Amount |
Cost |
Fair
Value (3) |
%
of Net
Assets |
|
CLO
- Equity(4)(5) |
||||||
|
522
Funding CLO 2021-7, Ltd. |
Subordinated
Notes (effective yield 0.00%,
4/23/2034)8 |
7/27/2023 |
$4,505,000 |
$266,073 |
$27,030 |
0.04% |
|
AGL
CLO 17, Ltd. |
Subordinated
Notes (effective yield 9.76%,
1/21/2035) |
5/6/2024 |
2,750,000 |
1,802,209 |
805,166 |
1.15% |
|
Aimco
CLO 10, Ltd. |
Subordinated
Notes (effective yield 8.27%,
7/22/2032) |
11/27/2023 |
11,071,800 |
5,860,213 |
4,484,055 |
6.33% |
|
Aimco
CLO 14, Ltd. |
Subordinated
Notes (effective yield 10.23%,
10/20/2038) |
7/17/2023 |
6,200,000 |
4,543,138 |
3,581,394 |
5.05% |
|
Allegro
XVII, Ltd. |
Subordinated
Notes (effective yield 13.70%,
7/25/2038) |
5/07/2025 |
1,875,000 |
1,488,932 |
1,134,987 |
1.60% |
|
Apidos
CLO XXV, Ltd. |
Subordinated
Notes (effective yield 0.00%,
1/20/2037)8 |
7/1/2025 |
6,000,000 |
1,769,368 |
1,496,784 |
2.11% |
|
Apidos
CLO XXXIII, Ltd. |
Subordinated
Notes (effective yield 9.87%,
10/24/2034)6 |
7/25/2024 |
22,780,000 |
12,053,371 |
9,770,868 |
13.79% |
|
Apidos
CLO XXXIX, Ltd. |
Subordinated
Notes (effective yield 11.18%,
10/21/2038) |
5/2/2024 |
7,058,000 |
4,477,670 |
3,548,254 |
5.01% |
|
Ares
LIX CLO, Ltd. |
Subordinated
Notes (effective yield 18.85%,
4/25/2034) |
12/7/2023 |
8,000,000 |
4,125,084 |
2,231,943 |
3.15% |
|
Ares
LV CLO, Ltd. |
Subordinated
Notes (effective yield 11.40%,
10/15/2037) |
8/19/2025 |
7,500,000 |
5,055,380 |
3,330,010 |
4.70% |
|
Ares
LVI CLO, Ltd. |
Subordinated
Notes (effective yield 14.14%,
1/25/2038) |
8/24/2023 |
4,751,000 |
2,726,273 |
2,076,736 |
2.93% |
|
Ares
LX CLO, Ltd. |
Subordinated
Notes (effective yield 21.35%,
7/18/2034) |
11/29/2023 |
1,600,000 |
745,336 |
461,279 |
0.65% |
|
Ares
LXXIV CLO, Ltd. |
Subordinated
Notes (effective yield 11.22%,
10/15/2037) |
7/23/2025 |
4,000,000 |
3,141,285 |
1,898,956 |
2.68% |
|
Audax
CLO 12, Ltd. |
Subordinated
Notes (effective yield 18.77%,
4/22/2037) |
3/03/2025 |
1,330,000 |
1,215,547 |
1,123,208 |
1.59% |
|
Ballyrock
CLO 16, Ltd. |
Subordinated
Notes (effective yield 12.36%,
7/20/2034) |
8/20/2024 |
5,867,000 |
3,206,398 |
2,308,931 |
3.26% |
|
Ballyrock
CLO 18, Ltd. |
Subordinated
Notes (effective yield 9.68%,
4/15/2038) |
8/16/2023 |
3,260,000 |
1,844,252 |
1,063,243 |
1.50% |
|
Barings
CLO, Ltd. 2019-III |
Subordinated
Notes (effective yield 15.31%,
1/20/2036)6 |
12/13/2023 |
7,695,466 |
3,405,880 |
2,122,282 |
3.00% |
|
Barings
CLO, Ltd. 2021-I |
Subordinated
Notes (effective yield 0.00%,
4/25/2034)8 |
7/17/2023 |
3,400,000 |
1,459,569 |
760,407 |
1.07% |
|
Barings
CLO, Ltd. 2025-I |
Subordinated
Notes (effective yield 11.47%,
4/20/2038) |
2/14/2025 |
6,000,000 |
4,867,473 |
3,781,959 |
5.34% |
|
Barings
CLO, Ltd. 2025-VIII |
Subordinated
Notes (effective yield 14.24%,
1/15/2039) |
12/03/2025 |
3,600,000 |
2,859,120 |
2,758,281 |
3.89% |
|
Benefit
Street Partners CLO XXIII,
Ltd. |
Subordinated
Notes (effective yield 20.08%,
4/25/2034) |
8/02/2023 |
10,000,000 |
5,995,262 |
5,182,323 |
7.31% |
|
Benefit
Street Partners CLO
XXXVIII,
Ltd. |
Subordinated
Notes (effective yield 8.88%,
1/25/2038) |
12/17/2024 |
5,000,000 |
4,577,254 |
3,361,870 |
4.75% |
|
Birch
Grove CLO 3, Ltd. |
Subordinated
Notes (effective yield 9.14%,
1/19/2038) |
9/4/2024 |
8,602,500 |
6,774,666 |
4,376,618 |
6.18% |
|
CIFC
Funding 2020-II, Ltd. |
Subordinated
Notes (effective yield 11.49%,
10/20/2034) |
2/11/2025 |
9,032,000 |
4,567,308 |
3,470,369 |
4.91% |
|
Elmwood
CLO 17, Ltd. |
Subordinated
Notes (effective yield 8.62%,
7/17/2037) |
8/13/2025 |
17,500,000 |
11,177,036 |
9,262,543 |
13.07% |
|
Elmwood
CLO VII, Ltd. |
Subordinated
Notes (effective yield 5.36%,
1/17/2034) |
7/17/2023 |
3,400,000 |
1,542,041 |
827,546 |
1.17% |
|
Empower
CLO 2022-1, Ltd. |
Subordinated
Notes (effective yield 9.46%,
10/20/2037) |
9/27/2024 |
9,500,000 |
7,233,696 |
4,181,068 |
5.90% |
|
Galaxy
XXII CLO, Ltd. |
Subordinated
Notes (effective yield 6.31%,
4/16/2034) |
12/15/2023 |
3,560,000 |
1,923,511 |
986,151 |
1.39% |
|
MidOcean
Credit CLO XI, Ltd. |
Subordinated
Notes (effective yield 14.23%,
1/18/2036) |
1/12/2024 |
6,250,000 |
3,713,384 |
2,275,269 |
3.21% |
|
MidOcean
Credit CLO XIV, Ltd. |
Subordinated
Notes (effective yield 8.10%,
4/15/2037)6 |
2/15/2024 |
6,750,000 |
4,299,873 |
2,936,473 |
4.14% |
|
Neuberger
Berman Loan Advisers
CLO
41, Ltd. |
Subordinated
Notes (effective yield 12.45%,
4/15/2034) |
11/1/2023 |
4,500,000 |
2,402,581 |
1,298,962 |
1.83% |
|
Niagara
Park CLO, Ltd. |
Subordinated
Notes (effective yield 15.25%,
1/17/2038) |
12/1/2023 |
7,850,000 |
4,268,420 |
2,694,351 |
3.80% |
|
Issuer
(1)(7) |
Investment
Description |
Acquisition
Date
(2) |
Principal
Amount |
Cost |
Fair
Value (3) |
%
of Net
Assets |
|
Niagara
Park CLO, Ltd. |
Subordinated
Notes (effective yield 11.67%,
1/17/2038) |
11/6/2024 |
$79,398 |
$77,177 |
$77,100 |
0.11% |
|
Oaktree
CLO 2019-3, Ltd. |
Subordinated
Notes (effective yield 11.96%,
1/20/2038) |
6/12/2025 |
3,500,000 |
1,991,588 |
1,238,292 |
1.76% |
|
OCP
CLO 2015-9, Ltd. |
Subordinated
Notes (effective yield 11.29%,
1/15/2037) |
12/6/2023 |
21,847,700 |
7,806,134 |
5,399,162 |
7.62% |
|
OCP
CLO 2017-13, Ltd. |
Subordinated
Notes (effective yield 7.18%,
11/26/2037) |
5/13/2025 |
17,897,237 |
5,818,714 |
4,508,360 |
6.36% |
|
OHA
Credit Partners XIII, Ltd. |
Subordinated
Notes (effective yield 11.65%,
10/21/2034) |
7/17/2023 |
2,950,000 |
1,668,496 |
1,143,912 |
1.61% |
|
Riverbank
Park CLO, Ltd. |
Subordinated
Notes (effective yield 12.81%,
1/25/2038) |
11/4/2025 |
9,950,000 |
7,583,726 |
5,621,025 |
7.93% |
|
RR
12, Ltd. |
Subordinated
Notes (effective yield 0.00%,
1/15/2036)8 |
7/31/2024 |
8,542,000 |
1,457,461 |
983,474 |
1.39% |
|
RR
6, Ltd. |
Subordinated
Notes (effective yield 0.00%,
4/15/2036)8 |
4/25/2024 |
2,206,250 |
708,449 |
144,055 |
0.20% |
|
Silver
Point CLO 4, Ltd. |
Subordinated
Notes (effective yield 14.64%,
4/15/2037) |
2/28/2025 |
7,140,000 |
4,480,506 |
1,843,769 |
2.60% |
|
Voya
CLO 2020-2, Ltd. |
Subordinated
Notes (effective yield 11.22%,
7/19/2034) |
8/02/2023 |
13,597,500 |
9,740,815 |
7,235,149 |
10.21% |
|
Voya
CLO 2020-3, Ltd. |
Subordinated
Notes (effective yield 10.62%,
1/20/2038) |
8/3/2023 |
5,798,000 |
3,710,656 |
2,673,436 |
3.77% |
|
Total
CLO Equity |
$170,431,325 |
$120,487,050 |
170.06% | |||
|
CLO
- Debt(4) |
||||||
|
Apidos
CLO XXXIII, Ltd. |
12.22%
(3M Term SOFR + 8.55%,
4/24/2038) |
4/23/2025 |
$250,000 |
$230,607 |
$227,506 |
0.32% |
|
Total
CLO Debt |
$230,607 |
$227,506 |
0.32% | |||
|
Real
Estate(9) |
||||||
|
Moores
Crossing - Travis County, TX |
7/14/2023 |
$4,000,000 |
$4,003,879 |
$2,175,000 |
3.07% | |
|
Total
Real Estate |
$4,003,879 |
$2,175,000 |
3.07% | |||
|
Total
Investments |
$174,665,811 |
$122,889,556 |
173.45% | |||
|
Cash
Equivalents |
||||||
|
City
National Bank MMDA |
Money
Market Deposit Account |
$2,037,879 |
$2,037,879 |
$2,037,879 |
2.88% | |
|
U.S.
Bank MMDA |
Money
Market Deposit Account |
775,034 |
775,034 |
775,034 |
1.09% | |
|
Total
Cash Equivalents |
$2,812,913 |
$2,812,913 |
3.97% | |||
|
Total
Investments and Cash
Equivalents |
$177,478,724 |
$125,702,469 |
177.42% |
|
Six
Months Ended
March
31, 2026 | ||
|
Investment
Income |
||
|
Interest
income |
$12,661,704 | |
|
Total
investment income |
12,661,704 | |
|
Expenses |
||
|
Interest
expense |
5,539,868 | |
|
Management
fees |
1,572,708 | |
|
Incentive
fees |
253,737 | |
|
Professional
fees |
659,687 | |
|
Administration
and custodian fees |
331,722 | |
|
Insurance
expense |
119,173 | |
|
Printing
expense |
85,565 | |
|
Transfer
agent fees |
89,255 | |
|
Trustees'
fees and expenses |
62,329 | |
|
Other
expenses |
58,757 | |
|
Total
expenses |
8,772,801 | |
|
Net
Investment Income |
3,888,903 | |
|
Net
Realized and Unrealized Gain (Loss) |
||
|
Net
realized gain (loss) on investments |
(12,835,266) | |
|
Net
change in unrealized appreciation (depreciation) on
investments |
(37,716,591) | |
|
Net
Realized and Unrealized Gain (Loss) |
(50,551,857) | |
|
Net
Decrease in Net Assets Attributable to Common Shares from
Operations |
$(46,662,954) | |
|
Six
Months Ended
March
31, 2026 |
Year
Ended
September
30, 2025 | |||
|
Net
increase (decrease) in net assets from
operations: |
||||
|
Net
investment income |
$3,888,903 |
$15,208,865 | ||
|
Net
realized gain (loss) on investment
transactions |
(12,835,266) |
(17,706,825) | ||
|
Net
change in unrealized appreciation (depreciation) on investments
|
(37,716,591) |
(3,504,909) | ||
|
Net
decrease in net assets resulting from
operations |
(46,662,954) |
(6,002,869) | ||
|
Distributions
to shareholders from: |
||||
|
Net
investment income |
(12,401,194) |
(10,363,754) | ||
|
Return
of capital |
— |
(13,459,803) | ||
|
Total
distributions to shareholders |
(12,401,194) |
(23,823,557) | ||
|
Capital
share transactions |
||||
|
Net
increase (decrease) in net assets resulting from beneficial
interest: |
||||
|
Issuance
of common shares |
— |
40,303,512 | ||
|
Reinvestment
of dividends |
— |
1,823,533 | ||
|
Net
increase in net assets from capital share
transactions |
— |
42,127,045 | ||
|
Total
increase (decrease) in net assets |
(59,064,148) |
12,300,619 | ||
|
Net
assets at the beginning of the period |
129,913,622 |
117,613,003 | ||
|
Net
assets at the end of the period |
$70,849,474 |
$129,913,622 | ||
|
Six
Months Ended
March
31, 2026 | ||
|
Cash
flows from operating activities |
||
|
Net
decrease in net assets resulting from
operations |
$(46,662,954) | |
|
Adjustments
to reconcile net decrease in net assets from operations to net cash
provided by operating activities: |
||
|
Purchases
of investments, net of change in payable for investments
purchased |
(14,513,070) | |
|
Proceeds
from disposition of investments and reductions to investment cost value,
net of change in receivable
for
investments sold (1) |
44,223,753 | |
|
Net
amortization on investments |
(332) | |
|
Amortization
of deferred issuance costs on preferred shares and credit
facility |
2,716,605 | |
|
Net
realized loss on investments |
12,835,266 | |
|
Net
change in unrealized depreciation on
investments |
37,716,591 | |
|
Changes
in assets: |
||
|
Decrease
in interest receivable |
2,582,483 | |
|
Decrease
in prepaid expenses and other assets |
119,172 | |
|
Changes
in liabilities: |
||
|
Decrease
in incentive fee payable |
(417,006) | |
|
Increase
in management fee payable |
87,989 | |
|
Decrease
in interest payable on preferred shares |
(105,147) | |
|
Decrease
in professional fees payable |
(429,547) | |
|
Increase
in administration and custodian fees payable |
93,713 | |
|
Increase
in other payables and accrued expenses |
217,195 | |
|
Net
cash provided by operating activities |
38,464,711 | |
|
Cash
flows from financing activities |
||
|
Borrowings
on credit facility |
18,500,000 | |
|
Repayments
on credit facility |
(17,250,000) | |
|
Proceeds
from the issuance of preferred shares |
47,500,000 | |
|
Deferred
issuance costs for the issuance of preferred
shares |
(2,466,224) | |
|
Payments
on preferred shares redeemed, net of redemptions
payable |
(72,000,000) | |
|
Dividends
paid to shareholders |
(12,401,194) | |
|
Net
cash used in financing activities |
(38,117,418) | |
|
Net
increase in cash and cash equivalents |
347,293 | |
|
Cash
and cash equivalents, beginning of period |
2,465,620 | |
|
Cash
and cash equivalents, end of period |
$2,812,913 |
|
Supplemental
information: |
||
|
Cash
paid for interest on preferred shares |
$2,770,675 |
|
Six
Months
Ended
March
31,
2026 |
Year
Ended September 30, | |||||||||
|
2025 |
2024 |
2023(7) |
2022 |
|||||||
|
Per
Share Operating Data |
||||||||||
|
Net
asset value, beginning of period |
$6.13 |
$7.64 |
$8.42 |
$10.39 |
$11.69 |
|||||
|
Income
(loss) from investment operations: |
||||||||||
|
Net
investment income (1) |
0.18 |
0.81 |
1.19 |
0.05 |
0.50 |
|||||
|
Net
realized and unrealized gain (loss) (2) |
(2.38) |
(1.13) |
(0.74) |
(1.20) |
(0.80) |
|||||
|
Total
from investment operations |
(2.20) |
(0.32) |
0.45 |
(1.15) |
(0.30) |
|||||
|
Dividends
to shareholders from: |
||||||||||
|
Net
investment income (3) |
(0.59) |
(0.55) |
(0.03) |
(0.43) |
(0.73) |
|||||
|
Net
realized gains (3) |
— |
— |
— |
— |
(0.18) |
|||||
|
Return
of capital (3) |
— |
(0.71) |
(1.20) |
(0.40) |
(0.09) |
|||||
|
Total
dividends |
(0.59) |
(1.26) |
(1.23) |
(0.82) |
— |
(1.00) |
||||
|
Effect
of shares issued |
$— |
$0.07 |
$— |
$— |
$— |
|||||
|
Net
asset value, end of period |
$3.34 |
$6.13 |
$7.64 |
$8.42 |
$10.39 |
|||||
|
Per
share market value at beginning of period |
$5.82 |
$8.23 |
$8.18 |
$8.92 |
$10.49 |
|||||
|
Per
share market value at end of period |
$3.21 |
$5.82 |
$8.23 |
$8.18 |
$8.92 |
|||||
|
Total
Return based on Net Asset Value (4) |
(38.29)% |
(3.74)% |
6.07% |
(11.75)% |
(2.77)% |
|||||
|
Total
Return based on Market Value (5) |
(36.94)% |
(15.09)% |
17.21% |
0.39% |
(5.95)% |
|||||
|
Ratios/Supplemental
Data |
||||||||||
|
Net
assets, end of period (in thousands) |
$70,849 |
$129,914 |
$117,613 |
$98,751 |
$107,829 |
|||||
|
Ratio
of gross expenses to average net assets (6) |
16.68% |
13.85% |
12.92% |
7.42% |
3.27% |
|||||
|
Ratio
of net expenses to average net assets (6) |
16.68% |
13.85% |
12.92% |
6.72% |
3.09% |
|||||
|
Ratio
of net expenses before incentive fees to average net
assets
(6) |
16.20% |
11.36% |
9.72% |
N/A |
N/A |
|||||
|
Ratio
of net investment income to average net assets (6) |
7.39% |
11.72% |
15.10% |
0.56% |
4.53% |
|||||
|
Portfolio
turnover rate |
17.33% |
28.91% |
17.69% |
100.91% |
28.39% |
|||||
|
Asset
coverage of preferred shares and credit
facility |
220% |
258% |
285% |
N/A |
N/A |
|||||
|
Loan
Outstanding, End of Year/Period (in thousands) (8) |
$8,000 |
$6,750 |
N/A |
N/A |
$7,455 |
|||||
|
Asset
Coverage Ratio for Loan Outstanding (8) |
1,623% |
3,143% |
N/A |
N/A |
1,546% |
|||||
|
Asset
Coverage, per $1,000 Principal Amount of Loan
Outstanding
(8) |
$16,233 |
$31,434 |
N/A |
N/A |
$15,463 |
|||||
|
Weighted
Average Loans Outstanding (in thousands) (8) |
$2,526 |
$7,542 |
N/A |
$3,732 |
$8,051 |
|||||
|
Weighted
Average Interest Rate on Loans Outstanding (8) |
7.09% |
7.45% |
N/A |
7.94% |
4.50% |
|||||
|
Senior
Securities |
||||||||
|
Class and
Period Ended |
Total
Amount
Outstanding
Exclusive
of
Treasury
Securities
(1) |
Asset
Coverage
Per
Unit (2) |
Involuntary
Liquidating
Preference
Per
Unit (3) |
Average
Market
Value
Per
Unit (4) | ||||
|
Credit
Facility |
||||||||
|
March
31, 2026 |
$8,000,000 |
$16,233.31 |
$— |
N/A | ||||
|
September
30, 2025 |
$6,750,000 |
$31,434.17 |
$— |
N/A | ||||
|
8.75%
Series A Term Preferred Shares |
|
|||||||
|
September
30, 2025 |
$ |
$64.48 |
$25.00 |
$25.74 | ||||
|
September
30, 2024 |
$52,000,000 |
$ |
$ |
$ | ||||
|
7.125%
Series B Convertible Preferred
Shares |
|
|||||||
|
March
31, 2026 |
$3,517,000 |
$2,200.49 |
$1,000.00 |
N/A | ||||
|
September
30, 2025 |
$3,517,000 |
$2,579.17 |
$1,000.00 |
N/A | ||||
|
September
30, 2024 |
$11,517,000 |
$ |
$ |
N/A | ||||
|
7.50%
Series C Convertible Preferred
Shares |
||||||||
|
September
30, 2025 |
$20,000,000 |
$2,579.17 |
$1,000.00 |
N/A | ||||
|
7.375%
Series D Term Preferred Shares |
||||||||
|
March
31, 2026 |
$30,000,000 |
$55.01 |
$25.00 |
$25.17 | ||||
|
7.25%
Series E Convertible Preferred
Shares |
||||||||
|
March
31, 2026 |
$17,500,000 |
$2,200.49 |
$1,000.00 |
N/A |
|
As
of March 31, 2026 | |||||||
|
Level 1 |
Level 2 |
Level 3 |
Total | ||||
|
Assets |
|||||||
|
Cash
Equivalents |
$2,812,913 |
$— |
$— |
$2,812,913 | |||
|
Collateralized
Loan Obligations |
— |
— |
120,714,556 |
120,714,556 | |||
|
Real
Estate |
— |
— |
2,175,000 |
2,175,000 | |||
|
Total
Investments, at Fair Value |
$2,812,913 |
$— |
$122,889,556 |
$125,702,469 | |||
|
For
the Six Months Ended March 31, 2026 |
||||||
|
Collateralized
Loan
Obligations |
Real
Estate |
Total | ||||
|
Balance,
beginning of period |
$190,028,718 |
$2,175,000 |
$192,203,718 | |||
|
Purchases
of investments |
14,513,070 |
— |
14,513,070 | |||
|
Proceeds
from sales and paydowns of investments (1) |
(33,275,707) |
— |
(33,275,707) | |||
|
Net
realized gains (losses) |
(12,835,266) |
— |
(12,835,266) | |||
|
Accretion
of discount (premium) |
332 |
— |
332 | |||
|
Net
change in unrealized appreciation
(depreciation) |
(37,716,591) |
— |
(37,716,591) | |||
|
Balance,
end of period |
$120,714,556 |
$2,175,000 |
$122,889,556 | |||
|
Net
change in unrealized appreciation (depreciation) included in earnings
related to
investments
still held at the reporting date |
$(42,245,835) |
$— |
$(42,245,835) | |||
|
As
of March 31, 2026 | |||||||||
|
Carrying
Value |
Fair
Value |
Level 1 |
Level 2 |
Level 3 | |||||
|
Credit
Facility (1) |
$8,000,000 |
$8,000,000 |
$— |
$— |
$8,000,000 | ||||
|
7.125%
Series
B Convertible Preferred Shares (2) |
3,517,000 |
3,360,965 |
— |
— |
3,360,965 | ||||
|
7.375%
Series
D Term Preferred Shares (3) |
29,016,726 |
30,096,000 |
30,096,000 |
— |
— | ||||
|
7.25%
Series E Convertible Preferred Shares (2) |
16,739,041 |
16,368,800 |
— |
— |
16,368,800 | ||||
|
Total |
$57,272,767 |
$57,825,765 |
$30,096,000 |
$— |
$27,729,765 | ||||
|
Fair
Value as of
March
31, 2026 |
Valuation
Techniques |
Significant
Unobservable
Inputs |
Range |
Weighted
Average | |||||||
|
Low |
High |
||||||||||
|
Collateralized
Loan Obligations |
$119,416,284 |
Consensus
Pricing |
Indicative
Quotes |
0.60% |
99.5% |
45.9% | |||||
|
$1,298,272 |
Discounted
Cash Flow |
Discount
Rate |
20.0% |
20.0% |
20.0% | ||||||
|
Real
Estate |
2,175,000 |
Market
Approach |
Bid
Price |
54.4% |
54.4% |
54.4% | |||||
|
Total
Level 3 Investments |
$122,889,556 |
||||||||||
|
Total Facility |
Borrowings
Outstanding |
Amount
Available (1) | |||
|
Credit
Facility |
$30,000,000 |
$8,000,000 |
$22,000,000 |
|
Initial
Issuance
Date |
Redemption
Date |
Dividend
Rate |
Share
Amount |
Price
Per
share |
Total
Raise | |
|
Series
A Term
Preferred
Shares |
10/24/2023 |
11/3/2025 |
8.75% |
2,080,000 |
$25.00 |
$ |
|
Initial
Issuance
Date |
Redemption
Date |
Dividend
Rate |
Share
Amount |
Price
Per
share |
Total
Raise | |
|
Series
B Convertible
Preferred
Shares |
8/27/2024 |
8/27/2029 |
7.125% |
11,517 |
$1,000.00 |
$ |
|
As
of March
31, 2026 | |
|
Series
B Liquidation Preference |
$3,517,000 |
|
Less:
Unamortized deferred issuance costs(1) |
— |
|
Carrying
value |
$3,517,000 |
|
Fair
value |
$3,360,965 |
|
Fair
value price per share |
$955.63 |
|
Initial
Issuance
Date |
Redemption
Date |
Dividend
Rate |
Share
Amount |
Price
Per
share |
Total
Raise | |
|
Series
C Convertible
Preferred
Shares |
1/31/2025 |
3/30/2026 |
7.50% |
20,000 |
$1,000.00 |
$ |
|
Initial
Issuance
Date |
Redemption
Date |
Dividend
Rate |
Share
Amount |
Price
Per
share |
Total
Raise | |
|
Series
D Term
Preferred
Shares |
10/30/2025 |
10/30/2028 |
7.375% |
1,200,000 |
$25.00 |
$30,000,000 |
|
As
of March
31, 2026 | |
|
Series
D Liquidation Preference |
$30,000,000 |
|
Less:
Unamortized deferred issuance costs |
983,274 |
|
Carrying
value |
$29,016,726 |
|
Fair
value
(1) |
$30,096,000 |
|
Fair
value price per share
(1) |
$25.08 |
|
Initial
Issuance
Date |
Redemption
Date |
Dividend
Rate |
Share
Amount |
Price
Per
share |
Total
Raise | |
|
Series
E Convertible
Preferred
Shares |
10/30/2025 |
10/30/2030 |
7.25% |
17,500 |
$1,000.00 |
$17,500,000 |
|
As
of March
31, 2026 | |
|
Series
E Liquidation Preference |
$17,500,000 |
|
Less:
Unamortized deferred issuance costs |
760,959 |
|
Carrying
value |
$16,739,041 |
|
Fair
value
|
$16,368,800 |
|
Fair
value price per share
|
$935.36 |
|
Outstanding
Principal
Balance
as of | |
|
March
31, 2026 | |
|
Borrowings |
|
|
Credit
Facility |
$8,000,000 |
|
Preferred
Shares |
|
|
Series
B Convertible Preferred Shares |
3,517,000 |
|
Series
D Term Preferred Shares |
30,000,000 |
|
Series
E Convertible Preferred Shares |
17,500,000 |
|
Total |
$59,017,000 |
|
Weighted
average interest rate |
7.27% |
|
Six
Months Ended March
31,
2026 | |
|
Federal
tax cost of securities |
$154,527,132 |
|
Gross
unrealized appreciation |
20,138,679 |
|
Gross
unrealized depreciation |
(51,776,255) |
|
Net
unrealized appreciation (depreciation) |
$(31,637,576) |
|
Adviser |
Carlyle
Global Credit Investment Management L.L.C. |
|
Transfer
Agent |
Equiniti
Trust Company LLC, (formerly known as American Stock Transfer & Trust
Company) |
|
Legal
Counsel |
Dechert
LLP |
|
Ticker
Symbols |
|
|
Common Shares |
CCIF |
|
Preferred Shares |
CCID |
